Displaying 1 - 7 of 7
| Active Ingredient | DICLOFENAC POTASSIUM |
| Therapeutic Class | OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS |
| Indications | Short term treatment of mild to moderate pain where rapid onset of action is desired. Not supplied for chronic anti-inflammatory conditions. |
| Caution | Under Diclofenac Sodium. |
| Dose Range |
Adult: 25-50mg three times daily. Usually no more than a 5 day supply is needed. Primary dysmenorrhoea: 100mg initially, then 50mg 3 times daily to a maximum of 150mg daily. Children 1 year and over: 0.25-1ml/kg body weight daily depending on the sever |
| Drug Interactions | |
| Pregnancy | Avoid unless the potential benefit outweighs the risk. |
| Breast Feeding | Diclofenac is distributed in breastmilk and is not recommended in lactating wome More ... |
| Active Ingredient | DICLOFENAC SODIUM |
| Therapeutic Class | OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS |
| Indications | Pain and inflammation in rheumatic disorders in patients intolerant or resistant to aspirin and indomethacin. |
| Caution | G.I. irritation; allergic disorders (as for asp irin) but less frequent. c.f. prescribing in liver and renal disease p. 13; 28. |
| Dose Range |
Adult: 25-50mg every 6-8 hours or 75-150 mg in divided doses, or 100mg daily as a single dose using the Retard preparation. Take with food.Inj.: I.M. 25-50mg every 6-8 hours. Supp: 50mg at night or every 6-8 hours if tablets are not tolerated. See BDS sup |
| Drug Interactions | |
| Pregnancy | Avoid unless the potential benefit outweighs the risk. |
| Breast Feeding | Diclofenac is distributed in breastmilk and is not recommended in lactating wome More ... |
| Active Ingredient | IBUPROFEN |
| Therapeutic Class | OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS |
| Indications |
Mild to moderate pain. Alternative to aspirin or indomethacin, with less side effects. |
| Caution | G.I. irritation; allergic disorders (as for aspirin) but less frequent. May administer with meals or milk if G.I. upset occurs. C.f. prescribing in liver and renal disease p. 14; 31. |
| Dose Range | Adult: 400mg 3-4 times daily. Do not exceed 2400mg total daily dose. Pediatric: 4-10mg/kg every 6-8 hours to a maximum of 40mg/kg/day. See BDS supply protocols pg. 5. |
| Drug Interactions | |
| Pregnancy | Avoid unless the potential benefit outweighs the risk. |
| Breast Feeding | Ibuprofen is distributed in breastmilk. Use with caution in lactating women. |
| Active Ingredient | INDOMETHACIN |
| Therapeutic Class | OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS |
| Indications |
Pain and inflammation in rheumatic/musculo-skeletal disorders e.g. gout. To promote closure of patent ductus arteriosus in premature infants. |
| Caution | G.I. upset, frontal headaches, dizziness, abdominal pain, constipation, diarrhea. Contraindicated in peptic ulcers, salicylate hypersensitivity. C.f. prescribing in liver and renal disease p. 14; 33. |
| Dose Range |
100mg once a day, up to a maximum of 200mg in divided doses. See BDS supply protocols pg. 5. |
| Drug Interactions | |
| Pregnancy | Avoid unless the potential benefit outweighs the risk. |
| Breast Feeding | Indomethacin is distributed in breastmilk. Use with caution in lactating. |
| Active Ingredient | KETOPROFEN |
| Therapeutic Class | OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | MEFENAMIC ACID |
| Therapeutic Class | OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | NAPROXEN |
| Therapeutic Class | OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS |
| Indications | Mild to moderate pain and inflammation in rheumatic and musculo- skeletal disorders. |
| Caution | May cause gastro-intestinal irritation. c.f. prescribing in liver and renal disease p.15;33. |
| Dose Range |
250mg-1g as a single or in divided doses. Take with food. See BDS supply protocols pg. 5. |
| Drug Interactions | |
| Pregnancy | Avoid unless potential benefit outweighs the risk. |
| Breast Feeding | Naproxen is distributed in breastmilk. Use is not recommended in pregnant women. |